ERJ Podcast
ERJPodcast
Duration:12:44 min
Presenter:Marc Humbert, Chief Editor,ERJ
Interviewee:Leo Fabbri, Associate Editor,ERJ
Articles Discussed:
- Piper E, Brightling C, Niven R,et al.A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma.Eur Respir J2013;41: 330 - 338。Full Text
Subscribe to theERJPodcastviaiTunesorRSS
Files in this Data Supplement:
- Listen to podcast- February 2013